Stay informed with the latest litigation news. Explore now

Somatostatin-Dopamine Chimeric Analogs - EP2914280B1

EP2914280

IPSEN PHARMA
Application Number
EP13851845A
Filing Date
Oct 31, 2013
Status
No Opposition Filed Within Time Limit
Nov 9, 2018
Grant Date
Jan 3, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP2914280B1 was granted to Ipsen Pharma on Jan 3, 2018 following the initial filing on Oct 31, 2013 under the application number EP13851845A . The current legal status of the patent is No Opposition Filed Within Time Limit.

Patent Summary

Patent Family New

Patent Family

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents